In human breast tumors, inflammatory mononuclear cells (IMCs) are recruited by binding chemokine (C-C motif) ligand 2 (CCL2), which is synthesized by tumor and stromal cells, to chemokine receptor 2 (CCR2), which promotes neovascularization and tumor cell infiltration (141). This evidence concerns the gene CCL2 and neoplasm.